Compare HDFC Pharma And Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.97
2.07
NAV
₹19.29
₹41.79
Fund Started
14 Sep 2023
25 Jun 2018
Fund Size
₹2158.58 Cr
₹6668.95 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
19.13%
9.54%
3 Year
-
28.96%
5 Year
-
16.08%
Equity
97.30%
96.76%
Cash
2.70%
3.24%
Top 10 Holdings
Divi's Laboratories Ltd. | 8.56% |
Sun Pharmaceutical Industries Ltd. | 8.05% |
Lupin Ltd. | 6.07% |
Glenmark Pharmaceuticals Ltd. | 6.06% |
Max Healthcare Institute Ltd. | 5.93% |
Aster DM Healthcare Ltd. | 5.46% |
Alkem Laboratories Ltd. | 4.69% |
Anthem Biosciences Ltd. | 4.55% |
Ipca Laboratories Ltd. | 4.39% |
Cipla Ltd. | 4.27% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
14 Sep 2023
25 Jun 2018
